Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference

 Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference

PR Newswire

ANAHEIM, Calif., Jan. 8, 2014

ANAHEIM, Calif., Jan. 8, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.
(NASDAQ: QCOR) announced today that Don Bailey, the Company's President and
Chief Executive Officer, will present at the J.P. Morgan Healthcare Conference
in San Francisco on January 16, 2014 at 9:00 AM PT/12:00 PM ET.

A live webcast and subsequent archived replay of the presentation will be
accessible at http://ir.questcor.com/events.cfm. The replay will be available
for approximately 90 days after the event.

About Questcor


Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
treatment of patients with serious, difficult-to-treat autoimmune and
inflammatory disorders. Questcor also provides specialty contract
manufacturing services to the global pharmaceutical industry through its
wholly-owned subsidiary BioVectra Inc. For more information about Questcor,
please visit www.questcor.com. 

SOURCE Questcor Pharmaceuticals, Inc.

Website: http://www.questcor.com
Contact: EVC Group, Gregory Gin/Patty Eisenhaur, 646-445-4801/951-316-0577,
Janine McCargo, 646-688-0425
 
Press spacebar to pause and continue. Press esc to stop.